Skip to main content

Advertisement

Log in

18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this meta-analysis was to evaluate the prognostic value of standard uptake value (SUV) from serial Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in patients with head and neck cancer.

Methods

We searched for articles limited to head and neck cancer, dealt with the impact of SUV on survival and published in English. The endpoints were disease-free survival (DFS), overall survival (OS), and local control (LC). Two reviewers extracted data independently.

Results

Thirty-five studies were identified; of which, 26 studies involving 1,415 patients met the inclusion criteria. Pooled survival data suggested better DFS, OS, and LC in patients with low SUV of pre-treatment, and the odds ratio (OR) was 0.23, 0.24, and 0.27, respectively. Patients having tumors with low SUV of post-treatment also had significantly better DFS (OR = 0.17) and OS (OR = 0.28) than those with high SUV.

Conclusions

The present meta-analysis showed that 18F-FDG uptake, as measured by the SUV before treatment and metabolic response after treatment, are valuable for predicting long-term survival in head and neck cancer. High 18F-FDG uptake may be useful for identifying patients requiring more aggressive treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Allal AS, Dulguerov P, Allaoua M et al (2002) Standardized uptake value of 2-[18F] fluoro-2-deoxy-d-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol 20(5):1398–1404

    Article  PubMed  CAS  Google Scholar 

  • Allal AS, Slosman DO, Kebdani T et al (2004) Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-d-glucose. Int J Radiat Oncol Biol Phys 59(5):1295–1300

    Article  PubMed  CAS  Google Scholar 

  • Bernier J, Domenge C, Ozsahin M et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350(19):1945–1952

    Article  PubMed  CAS  Google Scholar 

  • Bonner JA, Harari PM, Giralt J et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354(6):567–578

    Article  PubMed  CAS  Google Scholar 

  • Brun E, Kjellén E, Tennvall J et al (2002) FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 24(2):127–135

    Article  PubMed  Google Scholar 

  • Byun BH, Na II, Cheon GJ et al (2008) Clinical significance of 18F-FDG uptake by primary sites in patients with diffuse large B cell lymphoma in the head and neck: a pilot study. Ann Nucl Med 22(8):645–651

    Article  PubMed  Google Scholar 

  • Chan SC, Chang JT, Wang HM et al (2009) Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: the role of standardized uptake value. Oral Oncol 45:52–58

    Article  PubMed  Google Scholar 

  • Chung MK, Jeong HS, Park SG et al (2009) Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer. Clin Cancer Res 15(18):5861–5868

    Article  PubMed  CAS  Google Scholar 

  • Cicone F, Loose D, Deron P et al (2008) Prognostic value of FDG uptake by the bone marrow in squamous cell carcinoma of the head and neck. Nucl Med Commun 29(5):431–435

    Article  PubMed  CAS  Google Scholar 

  • Cohen EEW, Lingen MW, Vokes EE (2004) The expanding role of systemic therapy in head and neck cancer. J Clin Oncol 22:1743–1752

    Article  PubMed  Google Scholar 

  • Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 80:11–20

    Article  Google Scholar 

  • Döbert N, Kovács AF, Menzel C et al (2005) The prognostic value of FDG PET in head and neck cancer. Correlation with histopathology. Q J Nucl Med Mol Imaging 49(3):253–257

    PubMed  Google Scholar 

  • Garden AS, Asper JA, Morrison WH et al (2004) Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma? Cancer 100:1171–1178

    Article  PubMed  Google Scholar 

  • Greven KM, Williams DW 3rd, Keyes JW Jr et al (1994) Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 74(4):1355–1359

    Article  PubMed  CAS  Google Scholar 

  • Greven KM, Williams DW 3rd, McGuirt WF Sr et al (2001) Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 23(11):942–946

    Article  PubMed  CAS  Google Scholar 

  • Halfpenny W, Hain SF, Biassoni L et al (2002) FDG-PET. A possible prognostic factor in head and neck cancer. Br J Cancer 86(4):512–516

    Article  PubMed  CAS  Google Scholar 

  • Hoshikawa H, Mitani T, Nishiyama Y et al (2009) Evaluation of the therapeutic effects and recurrence for head and neck cancer after chemoradiotherapy by FDG-PET. Auris Nasus Larynx 36(2):192–198

    Article  PubMed  Google Scholar 

  • Juweid ME, Stroobants S, Hoekstra OS et al (2007) Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 25:571–578

    Article  PubMed  Google Scholar 

  • Kao CH, Shiau YC, Shen YY et al (2002) Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99 m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography: comparison with 18-fluoro-2-deoxyglucose positron emission tomography. Cancer 94:1981–1986

    Article  PubMed  Google Scholar 

  • Kim SY, Roh JL, Kim JS et al (2008) Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity. Eur J Surg Oncol 34(2):208–215

    PubMed  CAS  Google Scholar 

  • Krishna SM, James S, Balaram P (2006) Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status. Virus Res 115:85–90

    Article  PubMed  CAS  Google Scholar 

  • Kunkel M, Reichert TE, Benz P et al (2003a) Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 97(4):1015–1024

    Article  PubMed  CAS  Google Scholar 

  • Kunkel M, Förster GJ, Reichert TE et al (2003b) Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma. Oral Oncol 39(2):170–177

    Article  PubMed  Google Scholar 

  • Kunkel M, Helisch A, Reichert TE et al (2006) Clinical and prognostic value of [(18)F]FDG-PET for surveillance of oral squamous cell carcinoma after surgical salvage therapy. Oral Oncol 42(3):297–305

    Article  PubMed  Google Scholar 

  • La TH, Filion EJ, Turnbull BB et al (2009) Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. Int J Radiat Oncol Biol Phys 74(5):1335–1341

    Article  PubMed  Google Scholar 

  • Lee SW, Cho KJ, Park JH et al (2005) Expressions of Ku70 and DNA-PKcs as prognostic indicators of local control in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 62:1451–1457

    Article  PubMed  CAS  Google Scholar 

  • Lee P, Weerasuriya DK, Lavori PW et al (2007) Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys 69:328–333

    Article  PubMed  Google Scholar 

  • Lee SW, Nam SY, Im KC et al (2008) Prediction of prognosis using standardized uptake value of 2–18F- fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas. Radiother Oncol 87:211–216

    Article  PubMed  CAS  Google Scholar 

  • Liao CT, Chang JT, Wang HM et al (2009) Pretreatment primary tumor SUVmax measured by FDG-PET and pathologic tumor depth predict for poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys 73(3):764–771

    Article  PubMed  Google Scholar 

  • Lin C, Itti E, Haioun C et al (2007) Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis. J Nucl Med 48:1626–1632

    Article  PubMed  Google Scholar 

  • Linecker A, Kermer C, Sulzbacher I et al (2008) Uptake of (18)F-FLT and (18)F-FDG in primary head and neck cancer correlates with survival. Nuklearmedizin 47(2):80–85

    PubMed  CAS  Google Scholar 

  • Lordick F, Ott K, Krause BJ et al (2007) PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol 8:797–805

    Article  PubMed  Google Scholar 

  • Machtay M, Natwa M, Andrel J et al (2009) Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer. Head Neck 31(2):195–201

    Article  PubMed  Google Scholar 

  • Minn H, Lapela M, Klemi PJ et al (1997) Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med 38(12):1907–1911

    PubMed  CAS  Google Scholar 

  • Nakao K, Mochiki M, Nibu K et al (2006) Analysis of prognostic factors of nasopharyngeal carcinoma: impact of in situ hybridization for Epstein–Barr virus encoded small RNA1. Otolaryngol Head Neck Surg 134:639–645

    Article  PubMed  Google Scholar 

  • Okada J, Oonishi H, Yoshikawa K et al (1994) FDG-PET for predicting the prognosis of malignant lymphoma. Ann Nucl Med 8(3):187–191

    Article  PubMed  CAS  Google Scholar 

  • Rege S, Safa AA, Chaiken L et al (2000) Positron emission tomography: an independent indicator of radiocurability in head and neck carcinomas. Am J Clin Oncol 23(2):164–169

    PubMed  CAS  Google Scholar 

  • Roh JL, Ryu CH, Choi SH et al (2007) Clinical utility of 18F-FDG PET for patients with salivary gland malignancies. J Nucl Med 48(2):240–246

    PubMed  Google Scholar 

  • Sanghera B, Wong WL, Lodge MA et al (2005) Potential novel application of dual time point SUV measurements as a predictor of survival in head and neck cancer. Nucl Med Commun 26(10):861–867

    Article  PubMed  Google Scholar 

  • Sasaki R, Komaki R, Macapinlac H et al (2005) [18F]fluorodeoxy-glucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol 23:1136–1143

    Article  PubMed  CAS  Google Scholar 

  • Schönberger J, Rüschoff J, Grimm D et al (2002) Glucose transporter 1 gene expression is related to thyroid neoplasms with an unfavorable prognosis: an immunohistochemical study. Thyroid 12(9):747–754

    Article  PubMed  Google Scholar 

  • Schwartz DL, Rajendran J, Yueh B et al (2004) FDG-PET prediction of head and neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck Surg 130(12):1361–1367

    Article  PubMed  Google Scholar 

  • Schwarz JK, Siegel BA, Dehdashti F et al (2008) Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer. Int J Radiat Oncol Biol Phys 71:180–186

    Article  PubMed  Google Scholar 

  • Seol YM, Kwon BR, Song MK et al (2010) Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy. Acta Oncol 49(2):201–208

    Article  PubMed  CAS  Google Scholar 

  • Spiro SG, Buscombe J, Cook G et al (2008) Ensuring the right PET scan for the right patient. Lung Cancer 59:48–56

    Article  PubMed  Google Scholar 

  • Suh C, Kang YK, Roh JL et al (2008) Prognostic value of tumor 18F-FDG uptake in patients with untreated extranodal natural killer/T-cell lymphomas of the head and neck. J Nucl Med 49(11):1783–1789

    Article  PubMed  Google Scholar 

  • Thorwarth D, Eschmann SM, Holzner F et al (2006) Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients. Radiother Oncol 80(2):151–156

    Article  PubMed  CAS  Google Scholar 

  • Torizuka T, Tanizaki Y, Kanno T et al (2009) Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer. AJR Am J Roentgenol 192(4):W156–W160

    Article  PubMed  Google Scholar 

  • van Tinteren H, Hoekstra OS, Smit EF et al (2002) Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 359:1388–1393

    Article  PubMed  Google Scholar 

  • Wieder HA, Beer AJ, Lordick F et al (2005) Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junction. J Nucl Med 46:2029–2034

    PubMed  CAS  Google Scholar 

  • Xie P, Yue JB, Fu Z et al (2010a) Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma. Ann Oncol 21(5):1078–1082

    Article  PubMed  CAS  Google Scholar 

  • Xie P, Yue JB, Zhao HX et al (2010b) Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma. J Cancer Res Clin Oncol 136(6):883–889

    Article  PubMed  CAS  Google Scholar 

  • Yao M, Smith RB, Hoffman HT et al (2009) Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-a long-term outcome report. Int J Radiat Oncol Biol Phys 74(1):9–14

    Article  PubMed  CAS  Google Scholar 

  • Yen RF, Hong RL, Tzen KY et al (2005) Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma. J Nucl Med 46(5):770–774

    PubMed  Google Scholar 

  • Yen TC, Lin CY, Wang HM et al (2006) 18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for Stage T4 nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 65(5):1307–1314

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank Dr. Huiqing Li for his assistance with this paper.

Conflict of interest

There is no conflict of interest among authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jinming Yu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xie, P., Li, M., Zhao, H. et al. 18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis. J Cancer Res Clin Oncol 137, 1085–1093 (2011). https://doi.org/10.1007/s00432-010-0972-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-010-0972-y

Keywords

Navigation